|
|
|
LONDON, Oct 20 (Reuters) - Britain's healthcare cost-effectiveness watchdog said on Tuesday it was 'minded not to recommend' UCB's drug Cimzia as a treatment option for rheumatoid arthritis. A National Institute for Health and...
67 WALL STREET, New York - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. (CBMX); Coventry Health Care (CVH); DARA...
Here's what you can expect from the pharmaceutical giant. What analysts say: Buy, sell, or waffle? By more than a 3-to-1 margin, buy recommendations outnumber holds, 14 to four. Revenue. Analysts are looking for $11.4 billion...
KENILWORTH, N.J., Oct. 15 /PRNewswire-FirstCall/ -- Schering-Plough (NYSE: SGP) today announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be reported in an oral presentation at...
PHILADELPHIA (MedPage Today) -- Early-stage rheumatoid arthritis patients for whom methotrexate alone is unlikely to forestall disease progression can be identified early on with two standard markers, a researcher said here.
The impact of zilpaterol hydrochloride (ZH) on carcass yield, composition, and tenderness was evaluated using 384 beef steers in a randomized complete block design. Main effects were the addition of 0 or 8.3 mg/kg of ZH for the...
Schering-Plough today announced that data on boceprevir, an investigational hepatitis C virus (HCV) protease inhibitor, will be reported in an oral presentation at the American Association for the Study of Liver Diseases...
The Healthcare Distribution Management Association (HDMA) honored excellence in pharmaceutical and consumer product manufacturing with the presentation of 10 Distribution Industry Awards for Notable Achievements in Healthcare...
PHILADELPHIA, Oct. 19 /PRNewswire/ -- At week 52, 63 percent of patients receiving SIMPONI 50 mg achieved at least a 20 percent improvement in arthritis signs and symptoms as measured by American College of Rheumatology (ACR...
ZURICH, Oct 19 (Reuters) - Swiss drugmaker Novartis AG said the U.S. Food and Drug Administration had requested more information on dosing proposed for its drug for 'smoker's lung', or chronic obstructive pulmonary disease....
